Myles Minter
Stock Analyst at William Blair
(4.95)
# 130
Out of 4,356 analysts
533
Total ratings
60.1%
Success rate
34.2%
Average return
Main Sectors:
Stocks Rated by Myles Minter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IONS Ionis Pharmaceuticals | Reiterated: Buy | n/a | $76.50 | - | 47 | May 28, 2026 | |
| BHVN Biohaven | Reiterated: Hold | n/a | $11.01 | - | 11 | May 28, 2026 | |
| BBIO BridgeBio Pharma | Reiterated: Buy | n/a | $66.26 | - | 7 | May 27, 2026 | |
| BIIB Biogen | Maintained: Buy | n/a | $196.00 | - | 29 | May 22, 2026 | |
| DNLI Denali Therapeutics | Maintained: Buy | n/a | $21.04 | - | 13 | May 22, 2026 | |
| MRNA Moderna | Maintained: Hold | n/a | $47.19 | - | 23 | May 22, 2026 | |
| ARCT Arcturus Therapeutics Holdings | Reiterated: Buy | n/a | $7.92 | - | 20 | May 19, 2026 | |
| LRMR Larimar Therapeutics | Reiterated: Buy | n/a | $3.48 | - | 18 | May 18, 2026 | |
| KRRO Korro Bio | Maintained: Buy | n/a | $13.41 | - | 11 | May 18, 2026 | |
| ARGX argenx SE | Reiterated: Buy | n/a | $835.99 | - | 17 | May 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $14.96 | - | 13 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $20.07 | - | 13 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.73 | - | 10 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $14.07 | - | 16 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $81 | $54.73 | +47.36% | 14 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.63 | - | 9 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.16 | - | 11 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.39 | - | 9 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6.95 | $6.91 | +0.65% | 24 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $7.07 | - | 12 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.85 | - | 13 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 | $93.01 | -3.24% | 19 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $14 | $13.49 | +3.78% | 8 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $158.30 | - | 30 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $447.54 | - | 31 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $234.48 | - | 62 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $301.98 | - | 16 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $13.35 | - | 1 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.21 | n/a | 3 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $5.31 | n/a | 3 | Sep 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $349.97 | n/a | 5 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.91 | n/a | 15 | Dec 29, 2022 |
Ionis Pharmaceuticals
May 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $76.50
Upside: -
Biohaven
May 28, 2026
Reiterated: Hold
Price Target: n/a
Current: $11.01
Upside: -
BridgeBio Pharma
May 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $66.26
Upside: -
Biogen
May 22, 2026
Maintained: Buy
Price Target: n/a
Current: $196.00
Upside: -
Denali Therapeutics
May 22, 2026
Maintained: Buy
Price Target: n/a
Current: $21.04
Upside: -
Moderna
May 22, 2026
Maintained: Hold
Price Target: n/a
Current: $47.19
Upside: -
Arcturus Therapeutics Holdings
May 19, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.92
Upside: -
Larimar Therapeutics
May 18, 2026
Reiterated: Buy
Price Target: n/a
Current: $3.48
Upside: -
Korro Bio
May 18, 2026
Maintained: Buy
Price Target: n/a
Current: $13.41
Upside: -
argenx SE
May 16, 2026
Reiterated: Buy
Price Target: n/a
Current: $835.99
Upside: -
May 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $14.96
Upside: -
May 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $20.07
Upside: -
May 12, 2026
Maintained: Buy
Price Target: n/a
Current: $2.73
Upside: -
May 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $14.07
Upside: -
May 8, 2026
Reiterated: Buy
Price Target: $81
Current: $54.73
Upside: +47.36%
May 8, 2026
Maintained: Hold
Price Target: n/a
Current: $0.63
Upside: -
May 8, 2026
Reiterated: Hold
Price Target: n/a
Current: $2.16
Upside: -
May 8, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.39
Upside: -
May 7, 2026
Reiterated: Buy
Price Target: $6.95
Current: $6.91
Upside: +0.65%
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $7.07
Upside: -
May 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.85
Upside: -
May 6, 2026
Reiterated: Buy
Price Target: $90
Current: $93.01
Upside: -3.24%
May 6, 2026
Reiterated: Buy
Price Target: $13 → $14
Current: $13.49
Upside: +3.78%
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $158.30
Upside: -
May 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $447.54
Upside: -
May 4, 2026
Maintained: Buy
Price Target: n/a
Current: $234.48
Upside: -
Apr 30, 2026
Maintained: Buy
Price Target: n/a
Current: $301.98
Upside: -
Mar 31, 2026
Maintained: Buy
Price Target: n/a
Current: $13.35
Upside: -
Dec 22, 2023
Rated: Hold
Price Target: n/a
Current: $4.21
Upside: n/a
Sep 28, 2023
Maintained: Buy
Price Target: n/a
Current: $5.31
Upside: n/a
Mar 3, 2023
Downgraded: Hold
Price Target: n/a
Current: $349.97
Upside: n/a
Dec 29, 2022
Rated: Hold
Price Target: n/a
Current: $4.91
Upside: n/a